Skip to main content

Table 4 Progression-free survival and overall survival of different risk groups

From: Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram

 

N

PFS (m)

P value

OS (m)

P value

Training set

 Low-risk

43

19.4 (9.8, 28.9)

<0.001

90.4 (60.7, 126.9)

0.003

 High-risk

34

4.0 (2.7, 5.2)

60.4 (60.0, 61.9)

Test set

 Low-risk

19

13.4 (6.9, 20.0)

<0.001

99.2 (49.8, 99.2)

0.009

 High-risk

14

3.8 (2.4, 5.3)

32.1 (6.0, 55.2)

  1. PFS  Progression-free survival, OS Overall survival
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us